Advertisement
Advertisement
U.S. Markets open in 1 hr 26 mins
Advertisement
Advertisement
Advertisement
Advertisement

Recordati Industria Chimica e Farmaceutica S.p.A. (RER1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
38.50+0.48 (+1.26%)
As of 09:15AM CEST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/27/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.29
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 349.75
52 Week Low 334.49
50-Day Moving Average 339.35
200-Day Moving Average 339.40

Share Statistics

Avg Vol (3 month) 310
Avg Vol (10 day) 33
Shares Outstanding 5205.4M
Implied Shares Outstanding 6N/A
Float 897.17M
% Held by Insiders 151.82%
% Held by Institutions 126.09%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41.12
Forward Annual Dividend Yield 42.83%
Trailing Annual Dividend Rate 31.05
Trailing Annual Dividend Yield 32.76%
5 Year Average Dividend Yield 42.50
Payout Ratio 469.44%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 21, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sep 30, 2022

Profitability

Profit Margin 18.38%
Operating Margin (ttm)28.75%

Management Effectiveness

Return on Assets (ttm)9.37%
Return on Equity (ttm)21.67%

Income Statement

Revenue (ttm)1.8B
Revenue Per Share (ttm)8.75
Quarterly Revenue Growth (yoy)25.90%
Gross Profit (ttm)1.15B
EBITDA 622.84M
Net Income Avi to Common (ttm)331.04M
Diluted EPS (ttm)1.70
Quarterly Earnings Growth (yoy)0.80%

Balance Sheet

Total Cash (mrq)346.61M
Total Cash Per Share (mrq)1.69
Total Debt (mrq)1.72B
Total Debt/Equity (mrq)106.85
Current Ratio (mrq)1.60
Book Value Per Share (mrq)6.18

Cash Flow Statement

Operating Cash Flow (ttm)485.2M
Levered Free Cash Flow (ttm)151.59M
Advertisement
Advertisement